The Medicines Company snaps up antibiotics firm Rempex

8th December 2013

The Medicines Company has snapped up antibiotics group Rempex in a deal potentially worth around $474 million.

The company is shelling out $140 million upfront and up to $334 million in development, regulatory and commercial milestones for access to San Diego-based Rempex’ promising pipeline of antibacterial drug candidates, including Carbavance.

Read at source at pharmatimes.com


Leave a Reply

Your email address will not be published.

+ 51 = 53

« back to posts